News
Filter
-
Two major UK decisions announced on use of Alzheimer’s drug, lecanemab
-
Drug trial offers hope to 200,000 people with ‘hidden’ lung condition
-
Raising awareness of NTM pulmonary disease and its new Standards of Care
-
LifeArc funds innovative rare liver disease clinical trial
-
New smartphone app offers hope in the fight against neglected tropical diseases
-
Bronchiectasis: an overlooked lung condition with untapped commercial and research potential
-
Cambridge Science Centre opens new facility that will educate and inspire the next generation of scientists
-
Research shows potential ‘life-transforming’ mole reversal therapy in rare condition
-
LifeArc announces research funding boost to address dengue fever amid growing global health threat
-
LifeArc co-funds a new blood test that could prevent sudden child deaths caused by hereditary heart condition
-
The new LifeArc identity: More than just a fresh coat of paint
-
New partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development
